Provided by Tiger Trade Technology Pte. Ltd.

TRANSCENTA-B

0.850
-0.130-13.27%
Volume:2.03M
Turnover:1.78M
Market Cap:385.05M
PE:-1.73
High:0.980
Open:0.980
Low:0.780
Close:0.980
52wk High:5.800
52wk Low:0.780
Shares:453.00M
HK Float Shares:453.00M
Volume Ratio:2.62
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.490
ROE:-26.76%
ROA:-9.62%
PB:0.60
PE(LYR):-1.73
PS:11.63

Loading ...

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Yesterday

Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of Hicb Continuous Bioprocessing Technologies

THOMSON REUTERS
·
Yesterday

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Yesterday

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Yesterday

Transcenta Updates Board Structure and Committee Line-up

Bulletin Express
·
Aug 28

Transcenta Files List of Directors, Board Committee Roles and Disclosure-Responsible Management

Reuters
·
Aug 28

Transcenta-B Reports Mid-Year Results: Net Loss Narrows 38.66% to RMB 67.3 Million

Stock News
·
Aug 28

Transcenta Appoints Prof. Genhong Cheng as Independent Non-Executive Director

Reuters
·
Aug 28

Transcenta HY26 Net Loss Narrows to RMB 67.35 Million; Revenue More than Doubled to RMB 23.6 Million

Reuters
·
Aug 28

Transcenta Announces Online Release of 9 Sep 2026 EGM Circular and Offers Shareholders Print-or-Email Options

Bulletin Express
·
Aug 25

Transcenta Alerts Investors to Online Availability of 9 Sept 2026 EGM Circular and Offers Free Printed Copies on Request

Bulletin Express
·
Aug 25

Transcenta offloads Hangzhou CDMO assets to WuXi Biologics subsidiary for RMB190 million; shareholders to vote on 9 September 2026

Bulletin Express
·
Aug 25

TRANSCENTA-B Calls 9 Sept 2026 EGM to Approve Asset Purchase Agreement

Bulletin Express
·
Aug 25

Transcenta Holding Announces Extraordinary General Meeting

Reuters
·
Aug 25

Transcenta Sets 28 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 12

Transcenta Sets Board Meeting to Review Interim Results, Dividend Proposal

Reuters
·
Aug 12

Hong Kong Morning Market Recap | Hang Seng Index Edges Up 0.15% | Domestic AI Models Lead Tech Sector Gains

Stock News
·
Aug 07

Hong Kong Stock Alert | TRANSCENTA-B Surges Over 11% Pre-Noon, Plans to Sell CDMO Assets for 190 Million Yuan

Stock News
·
Aug 07

Transcenta Holding Says Unit to Sell CDMO Assets for Rmb190.0 Million

Reuters
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07